Progesterone (P4) stimulates proliferation of the mammary epithelium by a mechanism that involves paracrine signaling mediated from progesterone receptor (PR)-positive to neighboring PR-negative cells. Here we used a primary mouse mammary epithelial cell (MEC) culture system to define the molecular mechanism by which P4 regulates the expression of target gene effectors of proliferation including the paracrine factor receptor and activator of nuclear factor B ligand (RANKL). MECs from adult virgin mice grown and embedded in three-dimensional basementmembrane medium resemble mammary ducts in vivo structurally and with respect to other properties including a heterogeneous pattern of PR expression, P4 induction of RANKL and other target genes in a PR-dependent manner, and a proliferative response to progestin. RANKL was demonstrated to have multiple functional P4-responsive enhancers that bind PR in a hormonedependent manner as detected by chromatin immunoprecipitation assay. P4 also stimulated recruitment of signal transducer and activator of transcription (Stat)5a to RANKL enhancers through an apparent tethering with PR. Analysis of primary MECs from Stat5a knockout mice revealed that P4 induction of RANKL and a broad range of other PR target genes required Stat5a, as did P4-stimulated cell proliferation. In the absence of Stat5a, PR binding was lost at selective RANKL enhancers but was retained with others, suggesting that Stat5a acts to facilitate PR DNA binding at selective sites and to function as a coactivator with DNA-bound PR at others. These results show that RANKL is a direct PR target gene and that Stat5a has a novel role as a cofactor in PR-mediated transcriptional signaling in the mammary gland. (Molecular Endocrinology 27: 1808 -1824, 2013) T he mouse mammary gland is an important experimental system for modeling normal human breast because of analogous hormonal responses and developmental patterns (1). Genetically engineered mouse models and mammary gland transplantation experiments have established that progesterone (P4) is the primary ovarian steroid hormone required for proliferation and ductal side-branching of the mammary epithelium in the cycling adult animal (2-5) and for epithelial expansion and alveolar morphogenesis during pregnancy. Progesterone receptor (PR) is expressed only in ductal and luminal epithelial cells and not in other cells types including myoepithelial, stromal, and mammary stem cells (2, 6 -8). In the adult virgin mouse, PR is expressed heterogeneously in only 30%-40% of cells (8), and PR-positive cells largely segregate from proliferating PR-negative cells, indicating a paracrine mechanism of P4 control of proliferation (2). As direct evidence of paracrine signaling (8 -10), mam- Abbreviations: Areg, amphiregulin; ChIP, chromatin immunoprecipitation; 3D, three dimensional; DAPI, 4Ј,6-diamidino-2-phenylindole; GAS, ␥-interferon-activated sequence; IF, immunofluorescence; IHC, immunohistochemistry; K5, keratin 5; K8, keratin 8; KO, knockout; LDA, low-density array; MEC, mammary epithelial cell; P4, progesterone; PEM buffer, 80 mM potassium PIPES (pH 6.8), 5 mM EGTA (pH 7.0), 2 mM MgCl 2 ; PR, progesterone receptor; PRE, P4 response element; PRL, prolactin; qPCR, quantitative PCR; RANKL, receptor and activator of nuclear factor B ligand; SDS, sodium dodecyl sulfate; Stat, signal transducer and activator of transcription; WT, wild-type.
T he mouse mammary gland is an important experimental system for modeling normal human breast because of analogous hormonal responses and developmental patterns (1) . Genetically engineered mouse models and mammary gland transplantation experiments have established that progesterone (P4) is the primary ovarian steroid hormone required for proliferation and ductal side-branching of the mammary epithelium in the cycling adult animal (2-5) and for epithelial expansion and alveolar morphogenesis during pregnancy. Progesterone receptor (PR) is expressed only in ductal and luminal epithelial cells and not in other cells types including myoepithelial, stromal, and mammary stem cells (2, 6 -8) . In the adult virgin mouse, PR is expressed heterogeneously in only 30%-40% of cells (8) , and PR-positive cells largely segregate from proliferating PR-negative cells, indicating a paracrine mechanism of P4 control of proliferation (2) . As direct evidence of paracrine signaling (8 -10) , mam-mary epithelial cells (MECs) derived from PR knockout (PRKO) mice can undergo proliferation and alveogenesis when transplanted into the cleared fat pad of a wild-type (WT) mouse adjacent to cotransplanted PR-positive WT MECs (2, 9) . Several P4-induced target genes in the mouse mammary gland have been implicated as paracrine effectors of cell proliferation including Wnt4, amphiregulin (Areg), and receptor and activator of nuclear factor B ligand (RANKL) (11) (12) (13) (14) (15) (16) . Of these targets, RANKL has been shown to be the most crucial. RANKL is a member of the TNF␣ superfamily of cytokines that mediates its biologic effects through binding the transmembrane receptor RANK (17) . Dependent on the cell type, RANKL binding to RANK can activate a variety of downstream signaling cascades including IB kinase-␣/IB␣/nuclear factor B/cyclin D1 in the mammary gland (14, 18) . RANKL was initially defined as an essential factor for osteoclast differentiation and survival (19 -20) but since then has been found to be expressed in a variety of other tissues. In the mouse mammary gland, RANKL is required for epithelial cellular proliferation, survival, and alveologenesis during pregnancy as observed in RANKL-deficient mice (21) . The role of RANKL as a paracrine mediator of P4 was demonstrated by the ability of ectopically expressed RANKL to rescue the PRKO mammary phenotype. Transplantation of PRKO MECs engineered to constitutively express RANKL rescued ductal side branching and alveologenesis phenotypes in the absence of P4 (11) . With a bigenic mouse system that conditionally targets RANKL to ER-positive transmitter cells of the PRKO epithelium and thus a physiologic heterogeneous pattern of expression, the RANKL transgene also rescued the PRKO mammary phenotype (22) . In addition to proliferation of mature luminal epithelial cells, RANKL mediates P4-induced expansion and activation of ER/PR-negative mouse mammary stem cell populations by a paracrine pathway (23, 24) , and it is a paracrine mediator of P4 induction of Elf5 in PR-negative luminal progenitor cell populations required for secretory cell differentiation (25) . RANKL was also reported to be required for progestin-dependent tumorigenesis in different mouse mammary tumor models (14, 26) . Recent studies with normal human primary breast epithelial cells prepared as threedimensional (3D) "microstructure" cultures showed that P4 regulation of the RANKL paracrine signaling pathway required for proliferation is conserved in humans, further validating the mouse mammary gland as an experimental system (27) .
Stat5 (signal transducer and activator of transcription 5) is a member of a transcription factor family that mediates cytokine receptor signaling including the prolactin (PRL) receptor-Jak1/2 kinase/Stat5 axis that is responsible for regulation of target genes involved in alveologenesis during pregnancy and for lipid and milk production in the mammary gland during lactation (28, 29) . Deletion of Stat5 leads to proliferative and developmental defects during pregnancy similar to that of the PRKO mammary epithelium, and the mammary gland also fails to lactate (30, 31) . During puberty and in the adult virgin, Stat5 deletion does not lead to defective proliferation or ductal side-branching, indicating these developmental stages are primarily under the control of P4 (32) (33) (34) (35) . Stat5a has also been reported to be required for maintenance of luminal progentitor cells (36) . RANKL expression induced by PRL in the mammary gland in vivo (21) and with primary MECs in vitro (37) has been reported. In a gene microarray study, RANKL expression was reduced in mammary epithelium of PRLR-null mice compared with WT mice (33) . These data collectively suggest that RANKL may be a common target gene of both PR and PRL/Jak1/2/Stat5a signaling pathways and raises the question of whether PR and Stat5a cooperate to regulate RANKL.
Despite the importance of RANKL as a paracrine mediator of P4/PR signaling in the mammary gland, the molecular mechanism by which PR regulates RANKL expression is unknown. RANKL is a potential point of convergence of PR and Stat5, and the mechanism involved in cooperative gene regulation by PR and Stat5 also has not been explored directly. To address these questions, we used a basement membrane-embedded three-dimensional (3D) primary mouse MEC culture system that maintains expression of PR and functional responses to P4 in a manner that closely mimics mammary gland ducts in vivo. A chromatin immunoprecipitation (ChIP) assay with primary MECs in vitro was used for detection of PR and Stat5a binding to RANKL enhancers. These studies define RANKL as a direct target of PR and further showed a P4-dependent cobinding of Stat5a with RANKL enhancers in a manner associated with maximal P4 induction of RANKL expression. Stat5a was also required for P4-stimulated cell proliferation and for a broad range of P4-induced target genes indicating that Stat5a has an important role in PR-mediated transcriptional signaling in the mammary epithelium.
Antibodies
Different PR antibodies were used for specific applications including a rabbit anti-PR polyclonal antibody (A0098) (DAKO Corp) for immunohistochemistry (IHC), monoclonal anti-PR (10A9) (Immunotech) for IF assay of cell lines, a rabbit polyclonal anti-PR (Santa Curz-7208X) antibody that recognizes both PR-A and PR-B isoforms for ChIP assay, and monoclonal anti-PR (hPRa7) (Thermo) for IF assay of 3D MEC acini. Rabbit polyclonal anti-Ki67 (M7249) and monoclonal anti-Ki67 (KI67-MM1-L-CE) were obtained from Novocastra, and rabbit polyclonal anti-Stat5a (sc-1081) antibody was obtained from Santa Cruz Biotechnology, Inc. Rabbit antimouse IgG, whole molecule (55456) was purchased from ICN Biomedicals. Mouse monoclonal anti-␤-tubulin (05-661) was purchased from Millipore. Rabbit polyclonal antikeratin 5 (K5) (PRB-160P) was purchased from Covance. Rabbit monoclonal antikeratin 8 (K8) (Troma-1) was purchased from the Developmental Studies Hybridoma Bank (University of Iowa, Iowa City, Iowa). Rabbit monoclonal phospho-Stat5a (Y694) (C11C5) was purchased from Cell Signaling Technology.
Mouse mammary epithelial cell (MEC) lines
HC-11 mouse MECs mammary epithelial cells were maintained as previously described (38, 39) at 37°C and 5% CO 2 in RPMI 1640 medium supplemented with 10% bovine calf serum (HyClone), 5 g/mL insulin, 10 ng/mL epidermal growth factor, and 100 U/mL of penicillin and streptomycin. After cells reached confluency (2 ϫ 10 7 cells), they were incubated for 24 hours in differentiation medium (RPMI 1640 supplemented with 5 g/mL insulin, 1 /ml hydrocortisone and 10% dextrancoated charcoal-stripped donor horse serum) and then transduced with recombinant adenovirus expressing mouse PR-B (50 plaque-forming unit (pfu)/cell) as previously described (39) . At 48 hours after transduction, cells were treated in differentiation medium with various hormones indicated in Results and figure legends.
NMuMg mouse MECs were maintained at 37°C and 5% CO 2 in MEM supplemented with 10% fetal bovine serum HyClone; 5 g/mL insulin, 10 ng/mL epidermal growth factor, and 100 U/mL of penicillin and streptomycin. Cells were transfected with mouse PR-B (100 ng), RANKL enhancer luciferase reporters (100 ng), and pRL-TK-Renilla-luciferase (20 ng) indicated in Results and figure legends or a P4 response element (PRE)-TKluciferase control reporter (100 ng) using a 3:1 DNA:lipofectamine (Invitrogen) ratio in Opti-MEM. At 48 hours after transfection cells were treated for 24 hours with various hormones indicated in Results and figure legends.
Luciferase assay
NMuMg cells were transfected with mouse PR-B (100 ng), pRL-TK-Renilla-luciferase (20 ng), and RANKL enhancer luciferase reporter vectors (100 ng) (48 hours) and treated with either vehicle (EtOH) or R5020 (100 nM) for 24 hours. Cells were lysed with dual luciferase reporter lysis buffer according to manufacturer's protocol (Promega), and luciferase activity was measured in a 96-well plate with the FLUOstar Omega microplate reader (BMG Labtech) according to the manufacturer's instructions (Promega) and normalized to Renilla luciferase activity levels. For each treatment group cells were plated and analyzed in triplicate wells, and a minimum of 3 independent experiments was done for each RANKL enhancer.
Immunofluorescence (IF) imaging of HC-11 cells
HC-11 cells were plated on poly-D-lysine-coated coverslips (1.0 ϫ 10 4 cells) in RPMI 1640 medium supplemented with 10% bovine calf serum (HyClone), 5 g/mL insulin, 10 ng/mL epidermal growth factor, and 100 U/mL of penicillin and streptomycin. After 24 hours cells were transduced with recombinant adenovirus expressing mouse PR-B (50 plaque-forming unit (pfu)/cell) as previously described (39) in differentiation medium (RPMI 1640 supplemented with 5 g/mL insulin, 1 g/mL hydrocortisone and 10% dextran-coated charcoal-stripped donor horse serum). At 48 hours after transduction, cells were treated in differentiation medium with either vehicle, R5020 (100 nM), or PRL (3 g/mL) for 2 hours. Cells were fixed with 4% paraformaldehyde in PEM buffer (80 mM potassium PIPES, pH 6.8, 5 mM EGTA, pH 7.0, 2 mM MgCl 2 ) for 30 minutes at 4°C and quenched for autofluorescence with 1 mg/mL sodium borohydride in PEM buffer for 5 minutes. Cell permeabilization was performed in 0.5% Triton X-100 in PEM for 30 minutes at room temperature. Coverslips were blocked in 5% milk/TBST with 0.02% sodium azide for 1 hour at room temperature, followed by an overnight incubation at 4°C with the following primary antibodies: Stat5a rabbit polyclonal at 1:200 and PR mouse monoclonal at 1:100 (10A9). Antibodies were detected using secondary antibodies conjugated with either Alexa Fluor 594 (Abcam) for primary antibody Stat5a or Alexa Fluor 488 (Abcam) for primary antibody PR followed by adding 4Ј,6-diamidino-2-phenylindole (DAPI) (1:1000) and Vectashield mounting media (Vector Laboratories). Images were captured using a DeltaVision (Deconvolution) Image Restoration Microscope at ϫ40.
Primary mouse MEC 3D cultures
MECs were isolated from WT Balb/Jc (The Jackson Laboratory), WT FVB, or nulliparous Stat5a knockout (FVB) mice (Dr. Yi Li, Baylor College of Medicine, Houston, Texas) by methods similar to that described by Welm et al (40) . Whole mammary glands were excised, minced (Feather Disposable Scalpel, no. 21; Fisher Scientific), and digested with collagenase B (Roche, 2 mg/mL) for 1.5 hours at 37°C with shaking at 120 rpm. Cells were pelleted at 600 rcf relative centrifugal force for 10 minutes and washed 4 times with PBS by centrifugation at 450 rcf for 2 seconds to separate the mammary organoids from fat, fibroblasts, and red blood cells. These pelleted organoids that retain basement membrane attachments were trypsinized (0.05% Trypsin-EDTA, Gibco) for 12 minutes at 37°C and filtered with a 70 m cell strainer (BD Biosciences) to isolate a single-cell suspension of dissociated MECs. Isolated MECs were counted with the Vi-CELL XR (Beckman Coulter) and directly embedded in BD Matrigel (BD Biosciences) at 200 000 cells/150 L in 8-well chamber slides (BD Biosciences). Cultures were maintained at 37°C and 5% CO 2 in DMEM supplemented with 5% fetal bovine serum (HyClone), 5 g/mL insulin, 10 ng/mL epidermal growth factor, 1 g/mL hydrocortisone, and 100 U/mL of penicillin and streptomycin for 14 days of growth, exchanging media every other day. Cells were treated with hormones for various times indicated in Results and figure legends.
Analysis of hormone regulation of gene expression in primary MECs by real-time quantitative PCR
Primary MECs from at least 4 mice were isolated and pooled for each independent experiment. For each hormone treatment group, RNA was extracted and pooled from cells grown in 2 replicate wells of 8-chamber slides (BD Biosciences) and from 3 plating replicates. Matrigel was dissolved with RLT Buffer (150 L/chamber) (Qiagen) for 15 minutes at room temperature, and total RNA was extracted and purified according to the manufacturer's protocol (Qiagen). RNA concentration and quality were assayed by absorbance (A 230 , A 260 , A 280 ) with the NanoDrop 2000c (Thermo Scientific). cDNA was transcribed according to manufacturer's protocol using SuperScript III (Invitrogen) from total RNA (50 ng). Relative expression of RANKL was determined by real-time quantitative PCR (qPCR) with TaqMan PCR Master Mix (Applied Biosystems), whereas Wnt4, Areg, and PR were detected with SYBR Green PCR Master Mix (Applied Biosystems) using an ABI Prism 7500 Sequence Detector System (PE Applied Biosystems) according to manufacturer's instructions. Transcript levels were normalized to glyceraldehyde-3-phosphate dehydrogenase, and data were analyzed using the Q-Gene software (BioTechniques Software Library) (41) . Primer oligonucleotide pairs for qPCR are provided in Supplemental Table 1 published on the Endocrine Society's Journals Online web site at http://mend.endojournals.org).
Low density TaqMan tiled arrays (PE Applied Biosystems) were used to measure relative expression levels of multiple target genes from MECs grown in Matrigel. TaqMan low-density array (LDA) cards were analyzed using an ABI Prism 7900HT Sequence Detector System (PE Applied Biosystems). Transcript levels were normalized to glyceraldehyde-3-phosphate dehydrogenase, and data were analyzed using the SDS software (PE Applied Biosystems). The list of genes on the TaqMan LDA card is described in supplemental data (Supplemental Table 2 ).
ChIP assay of PR and Stat5a from primary MECs
For ChIP assay, mammary glands from 4 mice were harvested and pooled for each hormone treatment group. MECs were isolated from WT Balb/Jc (The Jackson Laboratory), WT FVB, or nulliparous Stat5a knockout (FVB) mice (Dr. Yi Li, Baylor College of Medicine, Houston, Texas). Chopped mammary gland tissue was digested with collagenase B (2 mg/mL, Roche) for 1.5 hours, and enriched MECs were collected as a cell pellet by centrifugation. Vehicle (EtOH), P4 (100 nM), or prolactin (3 g/mL) was added throughout the in vitro processing of the MECs (ϳ4.5 hours). Enriched MECs were then fixed with 1% paraformaldehyde for 10 minutes at room temperature, and fixation was squelched with 1.25 mM glycine for 5 minutes at room temperature. Fixed MECs were washed 3 times with PBS, centrifuged at 1500 rpm at 4°C for 10 minutes and stored at Ϫ80°C. For ChIP assay of the HC-11 cell line, cells were processed as described previously (38 -39) .
Optimal conditions for DNA sonication of HC-11 cell lines and primary MECs were determined to be different. HC-11 cell pellets were sonicated using a Branson-450 Sonifer with microtip in 10-second bursts followed by 1 minute of cooling on ice for 10 cycles. Mouse MECs were sonicated with the same microtip, but in 30-second bursts followed by 1 minute of cooling on ice for 4 cycles. Measurement of sheared DNA size was determined with the Agilent 2100 Bioanalyzer (Agilent Technologies). Most DNA fragments were in the size range of 500 -2000 bp. Ten percent of the sonicated chromatin was taken for input controls and processed with immunoprecipitated samples beginning at the point of the cross-linking reversal step. Remaining sonicated chromatin was incubated with 2.5 g of anti-PR (Santa Cruz Biotechnology, Inc; sc-7208X), 2.5 g anti-Stat5a (Santa Cruz Biotechnology, Inc; sc-1081), or 1 g control IgG (ICN Biomedicals; 55456) immobilized to Protein A magnetic beads (Invitrogen) overnight incubation at 4°C. Beads were washed repeatedly to remove nonspecifically bound DNA. DNA was eluted from the beads (55°C for 10 minutes), and cross-links were removed overnight at 65°C. Immunoprecipitated DNA was purified according to manufacturers protocol (Qiagen, Inc) and amplified by real-time qPCR with an ABI Prism 7500 Sequence Detector System (PE Applied Biosystems) using SYBR green PCR master mix (Applied Biosystems). PCR primers for enhancer regions of the RANKL gene are listed in Supplemental Table 3 . The percent input was calculated by normalizing the IP amplification product to the input amplification product to determine the percent input, and fold hormone recruitment was determined by calculating hormone recruitment over vehicle (EtOH), where EtOH was set to 1. To define nonspecific binding, samples were incubated with a control IgG antibody and analyzed by qPCR for each RANKL enhancer. A 50-to 100-fold increase of immunoprecipitated DNA with PRor Stat5a-specific antibodies was observed compared with IgG (data not shown). Additionally, immunoprecipitated DNA was amplified with primers to an intragenic region of RANKL, and no amplification was detected (data not shown).
Imaging of primary MEC 3D cultures by IHC
Primary MECs after growth in Matrigel were fixed with methacarn (60% methanol, 30% chloroform, 10% glacial acetic acid). Fixative was removed and each Matrigel plug was transferred to a plastic cryochamber containing 250 L of melted Histogel (Thermo Scientific) and 250 L of melted Histogel (Thermo Scientific) was placed on top of the embedded plug. After solidifying, the fixed Matrigel plugs were transferred to tissue cassettes, placed in 70% ethanol, and processed for paraffin embedding. Paraffin-embedded Matrigel plugs were sectioned (3-4 m) onto Plus slides (Fisher Scientific). Sections were deparaffinized in xylene, and then rehydrated through a graded ethanol series. Antigen retrieval was performed in 0.1 M Tris-HCl buffer, pH 9.0, for 10 minutes in a pressure cooker (96°C). Sections were blocked in 3% H 2 O 2 for 10 minutes, followed by a 1-hour incubation at room temperature with the following primary antibodies: Ki67 rabbit polyclonal at 1:2000 (Novocastra) and PR rabbit polyclonal at 1:100 (A0098; DAKO). Antibodies were detected using Envisionϩ HRPlabeled antirabbit polymer (30 minutes; DAKO).
Imaging of primary MEC 3D cultures by IF
Primary MECs were grown and Matrigel plugs were fixed, embedded, and sectioned as described above for IHC except that antigen retrieval was performed in 0.1 M citrate buffer, pH 6.0, for 20 minutes in a microwave (96°C). Sections were blocked in 5% BSA/0.5% Tween 20 in PBS for 1 hour for antibodies K5 and Keratin 8 (K8), followed by an overnight incubation at 4°C with the following primary antibodies: K5 rabbit polyclonal at 1:3000 (PRB-160P; Covance) and K8 rabbit monoclonal at 1:300 (Troma-1; Developmental Studies Hybridoma Bank). Antibody binding was detected using secondary antibodies conjugated with either Alexa Fluor 594 (Abcam) for primary antibody K5 or Alexa Fluor 488 (Abcam) for primary antibody K8 followed by adding VectashieldϩDAPI mounting media (Vector Laboratories).
For IF assay of 3D acini fixed in place without embedding and sectioning, primary MECs were grown in 40 L of Matrigel on cover-glass chamber slides (Thermo Scientific). Slides were fixed in 2% paraformaldehyde for 20 minutes at room temperature, washed in PBS-glycine, permeabilized with 0.5%Triton-X-100, and blocked with 10% goat serum, and incubated overnight with PR and Ki67 antibodies (Thermo PRa7 and Vector Ki67). Slides were subsequently incubated with Alexa-Fluorconjugated secondary antibodies according to manufactures protocol (Invitrogen), and nuclei were labeled with DAPI. Cover slides were maintained in 0.02% azide in PBS prior to and during imaging. Images were obtained under a ϫ20 long-working distance objective using a Nikon A1Rsi dual scanner confocal microscope. Each channel was captured individually, and merged images were created in Photoshop CS3 (Adobe).
Image capture and cell counting
A Leica DM LB light microscope connected to a MagnaFire digital camera was used to capture images from immunohistochemical staining. At least 15-20 individual ϫ40 fields were captured for counting from each sample group. The number of positively stained MEC nuclei was expressed as a percentage of the total number of luminal epithelial cells.
Immunoblot analysis
Primary MECs (4.5 ϫ 10 6 /well) grown in Matrigel for 7 days were isolated with dispase (BD Biosciences) (2 mL/well) according to manufacturer's protocol. MECs were collected as a pellet by centrifugation and washed several times with cold 1ϫ PBS. HC-11 cells and primary MECs were lysed in 50 mM Tris-base, pH 8.0, buffer plus 2 mM EDTA, 1 mM EGTA, 30 mM KCl, and 1% Igepal. Lysates containing equal amounts of total protein were boiled in 1% sodium dodecyl sulfate (SDS) sample buffer and electrophoresed on 7.5% polyacrylamide SDS gels. Remaining cell pellets were resuspended in 1% SDS sample buffer, boiled, and electrophoresed on 7.5% polyacrylamide SDS gels. Separated proteins were transferred to Immunobilon-P polyvinylidene fluoride membranes (Millipore) and incubated with anti-PR (PRa7), anti-phospho-Stat5 (C11C5), anti-Stat5a (sc-1081), or anti-␤-tubulin (05-661) in either 5% milk in TBS-T buffer (50 mM Tris-HCl, pH 7.4; 150 mM NaCl; and 0.1% Tween 20) for PR and ␤-tubulin, or in 5% Superblock-TBS-T (Thermo Scientific) for phospho-Stat5 and total Stat5a. Antibody binding to protein bands was detected by enhanced chemiluminescence (Amersham).
Statistics
All data were expressed as the mean Ϯ SD. Statistical comparisons were carried out by GraphPad Prism4 software (Graphpad Software). Student's t test was used for two-group comparisons. ANOVA using Bonferroni's post test was used for multiple treatment comparisons. Two-way ANOVA using Bonferroni's post test was used for comparisons between multiple groups.
Results
3D basement membrane-embedded culture system of primary mouse MECs for molecular mechanistic studies of PR signaling An in vitro system to culture primary MECs under conditions that maintain PR expression and recapitulate in vivo cellular signaling is needed to fully elucidate the molecular mechanisms by which PR regulates transcriptional signals and proliferation in the normal mammary gland. A central limitation is that expression of PR and other differentiation factors are rapidly lost with dissociated MECs grown as monolayers on plastic substratum and with permanent cell lines derived from normal MECs. As a solution to this problem, previous studies have shown that dissociated mouse MECs cultured with reconstituted basement membranes form polarized 3D acinar structures with a central lumen and can differentiate to express a functional estrogen receptor that responds appropriately to 17␤-estradiol and other hormones (42, 43) . Similar 3D culture systems have been extended to primary human breast epithelial cells for analysis of PR expression and functional response to P4 (44) . Organoids isolated from mouse mammary glands can also be grown short term in culture and maintain PR expression and functional responses to P4 (15, 45) .
In the present study, conditions were optimized for dissociated primary mouse MECs in culture with Matrigel as the source of basement membrane to maintain PR expression and functional responses to P4. MECs were embedded directly in Matrigel as opposed to growth on the surface, and insulin and EGF were provided as minimal growth factors. Although addition of prolactin stimulated growth, it also induced differentiation, ␤-casein expression, and down-regulation of PR, and thus was left out of the medium (data not shown). As shown by histologic sectioning and staining by hematoxylin and eosin, MECs grown for 14 days under these conditions formed 3D ductal acini consisting of a polarized layer of cells surrounding a lumen ( Figure 1A) . As shown by IF the cell layer consisted of both luminal cells detected by cytokeratin 8 (K8) localized in the apical region of the acinus and myoepithelial cells detected by cytokeratin 5 (K5) localized on the outside of the acinus ( Figure 1A ). PR protein expression was detected by IHC with antibodies specific to mouse PR ( Figure 1B) . The estimated percent of PRpositive cells was in the range of 15%-20% ( Figure 1C) , whereas up to 40% of cells are reported to be PR positive in the mammary gland of adult virgin mice in vivo (8) . PR is expressed as 2 protein isoforms, full length PR-B and amino-terminal truncated PR-A (46) . As shown by immunoblot assay, both forms of PR are expressed in isolated untreated MECs with a slightly higher amount of PR-A than PR-B ( Figure 1C ). Recombinant mouse PR-A and PR-B separately expressed by adenovirus vectors in HC-11 cells were used as controls for confirmation of the endogenous PR isoform bands from MECs ( Figure 1C) . Despite the PR quantitative difference, 3D acini cultures are responsive to P4. Continuous treatment (14 days) with the progestin agonist R5020 resulted in down-regulation of PR protein measured by IHC and PR mRNA by qPCR ( Figure 1D ). Also stimulation of cell proliferation induced by P4 was detected by IHC for Ki67 (Figure 1E) . Similar to the intact mammary gland in vivo, PR-positive and proliferating cells in 3C acinar cultures were observed to be segregated, indicating that P4-dependent proliferation is a paracrine-mediated event. As shown by dual IF of 3D acini fixed in place in Matrigel cultures, PR (green) and the proliferation marker Ki67 (red) were expressed in different cells (nuclei are blue by DAPI labeling) ( Figure 1F ). Separation of PR and ki67 expression was detected in multiple acini and only a rare cell expressed both markers (Supplemental Figure 1) .
To determine the extent to which P4 can induce expression of mammary gland PR target genes in the 3D culture system, we examined 40 known P4-induced target genes by use of a TaqMan low-density array (LDA) platform (Supplemental Table 1). The target genes were selected from the P4 transcriptome identified previously by microarray analysis of the intact mammary gland in vivo of ovariectomized mice treated acutely and incubated with a monoclonal antibody (PRa7) that recognizes mouse PR and an antibody to the proliferation marker ki67. Alexa-fluor-conjugated secondary antibodies were used to detect PR (green) and ki67 (red), and nuclei were labeled with DAPI (blue) at ϫ40 magnification. Inset is an expanded view of acini with 2 PR-positive cells (green) adjacent to a ki67 (red)-positive cell. Results are mean Ϯ SEM from 3 independent experiments. Student's t test was used to determine statistical significance. ns, not significant (P Ͼ .05); *, P Ͻ .05; **, P Ͻ .01; ***, P Ͻ .001; scale bar, 50 m. GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
with P4 (13). Using 2-fold or greater induction by hormone as a cut-off, 30 of these genes were significantly up-regulated by R5020 (Figure 2 ). Of these genes many are involved in cell proliferation including paracrine mediators such as: calcitonin (47), Wnt4 (11, 12) , Areg (16), and RANKL (11, 14, 15, 22, 45, 48 -50) . Independent confirmation of progestin induction of Wnt4, Areg, and RANKL was demonstrated in a separate experiment by gene-specific qPCR with RANKL showing the most robust fold hormone induction (Figure 3, A-C) . To determine the timing of progestin induction, these paracrine mediator genes were also measured by qPCR at different times of exposure to R5020 prior to the termination of 14 days of culture. Induction of RANKL and Areg was slow, requiring at least 48 hours for a significant increase, whereas induction of Wnt4 was detected earlier at 6 hours and 24 hours with maximal stimulation at 14 days ( Figure  3D ). These results are similar to microarray studies of intact mammary gland in vivo in which maximal P4 induction of RANKL and Areg required 76 hours of hormone whereas induction of Wnt4 occurred earlier (13) .
To determine whether effects of progestins are dependent on nuclear PR, we analyzed the influence of the PR antagonist RU486 (51) . Primary MEC 3D cultures were treated continuously for 14 days with either vehicle (EtOH), R5020, RU486, or R5020 and RU486 together, and RNA was prepared and analyzed by qPCR. No increase in RANKL expression over the vehicle (EtOH) was observed in the presence of RU486 alone whereas RU486 added together with R5020 completely inhibited induction of RANKL, Wnt4, and Areg ( Figure  4 ). Wnt4 has a higher basal level of expression in the absence of hormone (vehicle control) than the other genes, and RU486 suppressed expression of Wnt4 below the baseline level ( Figure 4 ). These data demonstrate that progestin induction of RANKL, Wnt4, and Areg is mediated by the classical nuclear PR. Collectively these results demonstrate that primary MECs grown in 3D basemembrane-embedded cultures closely resemble mammary gland ducts in vivo with respect to structural and cellular organization, PR expression pattern, progestin induction of key target genes in a PR-dependent manner, and proliferative response to progestin. , and Areg (panel C) was measured by genespecific qPCR. D, Primary MECs were grown and treated, and expression of RANKL, Areg, and Wnt4 was determined by qPCR as in panels A-C, except R5020 treatment times were for 6 hours, 24 hours, 48 hours prior to harvest or R5020 treatment was continuous for the entire 14 days. Results represent mean Ϯ SEM from 3 independent experiments. Student's t test was used to determine statistical significance between 2 hormone treatments. One-way ANOVA with Bonferroni's post test was used to determine statistical significance between multiple hormone treatments. ns, not significant (P Ͼ .05); *, P Ͻ .05; **, P Ͻ .01; ***, P Ͻ .001. GAPDH, glyceraldehydes 3-phosphate dehydrogenase; GOI, gene of interest.
RANKL is a direct PR target in MECs
Transcriptional regulation of RANKL has been most extensively studied in stromal cells of bone with respect to control by vitamin D and its receptor and by cytokines acting through Stat3 (52, 53) . Six conserved distal enhancer regions of mouse RANKL located between Ϫ88 to Ϫ16 kb upstream of the transcription start site have been identified as targets of vitamin D receptor or Stat3 and other transcription factors. These regions of RANKL have also been demonstrated to undergo enhanced histone H4 acetylation and recruitment of RNA polymerase II (52, 53) . To determine whether these enhancers contain potential PREs or ␥-interferon-activated sequence (GAS) sequences that bind Stats, an in silico analysis was performed using the Transcription Element Search System with the program recommended parameters for factors PR and Stat (54) . Using 4 separate databases (TRANSFAC, JASPAR, IMD, and CBIL-GibbsMat), Transcription Element Search System identified multiple consensus and divergent hexanucleotide PRE half-sites in all 6 RANKL enhancers and GAS sequences in enhancers D2, D3, D4, D5, and D6 ( Figure 5A and Supplemental Figure 2) . A ranking for each factor site was provided dependent on the Log-likelihood Score Filtering (54) . Each enhancer region linked to a TK-luciferase reporter vector (52, 53, 55) was assessed for activity with respect to P4 response by cotransfection with a mouse PR-B vector in mouse mammary epithelial NMuMg cells. R5020 significantly increased luciferase activity above vehicle (EtOH) for 5 of the RANKL enhancers (D1-D5), but failed to induce activity of D6 ( Figure 5B ). Enhancers D1 and D5 were the most active with respect to progestin induction with D5 approaching that of a consensus PRELuc used as a positive control ( Figure 5B ).
To determine whether each RANKL enhancer is a direct PR target, ChIP assays were performed initially with HC-11 mouse MECs ectopically expressing mouse PR-B and then confirmed with endogenous mouse PR in primary MECs. PR was expressed in HC-11 cells by transduction with adenovirus vectors containing recombinant mouse PR-B as previously described (38, 39) . Immunoprecipitated DNA fragments were analyzed by qPCR using primers spanning in the range of 150 -650 bp ( Ref. 52 and Supplemental Table 2 ) of the in silico identified PREs within each of the 6 enhancers ( Figure 5A and Supplemental Figure 2 ). Specificity of binding was determined by differential qPCR amplification of DNA fragments pulled down with a PR-specific antibody compared with an unrelated IgG amplification and from a random intragenic region of RANKL after immunoprecipitation with PR-specific antibody (data not shown). By these criteria PR bound specifically to enhancers D1-D5, and binding was significantly increased in response to R5020 treatment (1 hour) compared with the vehicle control ( Figure  5C ). Consistent with functional reporter gene assays, progestin-dependent recruitment of PR was not detected with enhancer D6 ( Figure 5C ). Because of the lower levels of endogenous PR expressed in only a fraction of cells in the mammary gland, methods were optimized for PR ChIP assay with primary mouse MECs. This required approximately 50 ϫ 10 6 total MECs per immunoprecipitation isolated from mammary glands pooled from 4 adult virgin Balb/c mice. MECs were incubated short term (ϳ4.5 hours) in suspension with either vehicle (EtOH) or P4 during the isolation and processing time and were then immediately fixed and processed for ChIP assay. Similar to results of ChIP assays with transduced HC-11 cells, endogenous PR in primary MECs bound specifically to RANKL enhancers D1-D5, and binding was increased significantly in response to P4 treatment ( Figure 5D ). As with HC-11 cells, PR binding to enhancer D6 was not increased by progestin ( Figure 5D ). These results support the conclusion that RANKL in MECs is a direct PR target containing P4-responsive enhancers that bind PR in a hormone-dependent manner.
PRL stimulates recruitment of Stat5a to selected enhancers but does not induce expression of RANKL in primary MECs
We also examined the influence of PRL on RANKL gene expression. Primary 3D MEC cultures were treated continuously for 14 days or 48 hours with and without PRL (3 g/mL), and RANKL expression was measured by . Progestin induction of paracrine growth factor genes is PR dependent. Primary MEC cultures in Matrigel were grown and treated for 14 days with either EtOH, R5020 (100 nM), RU486 (100 nM), or R5020 and RU486 (100 nM each). RANKL, Wnt4, and Areg were analyzed by qPCR as in Figure 3 . GAPDH, glyceraldehydes 3-phosphate dehydrogenase; GOI, gene of interest. Figure 6A ). Instead, a small decrease of base level RANKL was observed in the presence of PRL. Under the same conditions PRL treatment resulted in a robust induction of ␤-casein, indicating that the PRL/Jak/Stat5 signaling pathway is functional ( Figure 6B ). By ChIP assay, PRL treatment stimulated binding of Stat5a to enhancers D1, D3, D4, and D6 with minimal or no binding to the other RANKL enhancers ( Figure 6C ). These data indicate that despite the binding of Stat5a to selected enhancers, albeit with a different pattern of binding than PR, RANKL is not an inducible target gene of the PRL/Stat5a signaling axis, at least in MECs derived from adult virgin mice.
Stat5a is recruited to RANKL enhancers in response to P4
In addition to examining the effect of PRL on Stat5a binding by ChIP assay to RANKL enhancers, we also analyzed the effect of P4. In HC-11 cells transduced to express PR (B isoform) and with endogenous PR in primary MECs, P4 stimulated binding of Stat5a with all enhancers except D2 (Figures 7, A and  B) . Although, the effect of progestin on Stat5a binding with enhancer D2 was not statistically significant, a trend toward an increased binding was detected with HC-11 cells and primary MECs. Interestingly, enhancer D6 is the only region that did not show a progestin-dependent recruitment of PR, yet Stat5a was recruited to D6 in response to progestin. These data suggest a potential DNA looping mechanism within chromatin between Stat5a bound at D6 and PR at other enhancers. Stat5a activation as a transcription factor by cytokine signaling pathways involves tyrosine phosphorylation (Y694) and dimerization required for binding to GAS elements of target genes (56, 57) . By immunoblot assay of primary MEC 3D cultures with an antibody to tyrosine phosphorylated Stat5a (Y694), Y694 phosphorylation was unaffected by progestin treatment as compared with PRL that generated a robust stimulation ( Figure 7C ). The culture medium lacks PRL, and base level of Stat5a Y694 phosphorylation is very low, implying that Stat5a recruited by progestin is not activated as a transcription factor and may serve an alternate role. To determine mechanistically how Stat5a is recruited in response to P4, the effect of P4 on intracellular localization of Stat5a was analyzed by coimmunofluorescence microscopy of HC-11 cells trans- (54) , in which black boxes denote enhancers with both PRE and GAS sequences and white boxes denote enhancers with PREs only. B, RANKL enhancer activation in response to progestin. NMuMg cells transfected with individual RANKL enhancer-luciferase reporters (100 ng) and mouse PR-B (100 ng) were treated with either EtOH or R5020 (100 nM) for 24 hours. Luciferase activity was measured by a dual luciferase reporter assay, normalized to Renilla activity, and displayed as fold R5020 induction over vehicle (EtOH) setting the value of vehicle-treated NMuMg cells to 1. C, ChIP assay of PR binding to the RANKL distal enhancers in response to R5020 in HC-11 cells. Cells were transduced with adenovirus encoding mouse PR-B and treated for 1 hour with EtOH or R5020 (100 nM). Cells were processed for ChIP with an antibody to PR (sc-7208X). Immunoprecipitated DNA was amplified by qPCR using primers flanking RANKL enhancers (Supplemental Figure 1) . Amplified ChIP DNA was normalized to the input and displayed as fold R5020-induced PR recruitment over vehicle (EtOH), setting the value of vehicle treated HC-11 cells to 1. D, ChIP assay of PR binding to RANKL distal enhancers in primary MECs isolated from mouse mammary glands treated in vitro (4.5 hours) with EtOH or P4 (100 nM) and processed for ChIP with an antibody to PR (sc-7208X) as in panel C. Results are mean Ϯ SEM from 3 independent experiments. Student's t test was used to determine statistical significance. ns, not significant (P Ͼ .05); *, P Ͻ .05; **, P Ͻ .01; ***, P Ͻ .001; TSS, transcription start site. duced to express PR. As shown in Figure 7D , Stat5a and PR are distributed between the cytoplasm and nucleus in the absence of hormone (vehicle). As expected, short-term treatment with progestin (R5020) stimulated accumulation of PR in the nucleus but also stimulated nuclear translocation of Stat5a. Merging of IF signals showed that nuclear translocated Stat5a colocalized in cells with nuclear PR ( Figure 7D) . PRL, the activating hormone for Stat5a, stimulated nuclear translocation of Stat5a as expected but also promoted nuclear translocation of PR in the absence of P4 ( Figure 7D ). These data indicate the presence of a physical interaction of Stat5a with PR that promotes nuclear translocation of Stat5a in response to P4 and ultimately binding to the RANKL enhancers.
Stat5a is required for P4-induced expression of RANKL and for a proliferative response in MECs
To determine whether Stat5a has a role in P4/PR regulation of RANKL, we compared progestin induction of RANKL in primary MEC 3D cultures derived from WT and Stat5a knockout (KO) mice. Primary MECs were grown in Matrigel as in Figures 2 and 3 except for a change in mouse strain from Balb/C to FVB, because this is the background of the Stat5a knockout (KO) mice (32) . As shown in Figure 8A , the induction of RANKL by R5020 with MECs from WT mice was dramatically reduced compared with MECs from Stat5a KO mice. Only a small fold induction by R5020 was observed in Stat5a KO MECs and it was not statistically significant ( Figure  8A ). Progestin induction of Wnt4 and Areg was also abrogated in MECs from Stat5a KO mice ( Figure 8A ). To determine whether Stat5a has a more global effect on P4/PR regulation of gene transcription, a broader range of P4-induced mammary gland target genes was analyzed by high throughput TaqMan LDA qPCR as in Figure 2 . Of the 27 target genes that were induced greater than 2-fold by R5020 in WT MECs from FVB mice, all but 2 genes (Bdnf and Rspo1) exhibited a substantially diminished or complete loss of response in Stat5 KO MECs ( Figure 8B ). These data show a general requirement of Stat5a for maximal P4 induction of gene expression.
The reduced response to progestin in Stat5a KO MECs was not due to altered levels of PR expression. As detected by IHC of sections from primary 3D MEC cultures, PR levels were similar in MECs derived from WT and Stat5a KO mice ( Figure 8C ). The percent of PR-positive cells in acini was not significantly different between WT and Stat5a KO MECs, and treatment with progestin downregulated PR in both cell types ( Figure 8C ). Although not statistically significant, a slight increase of percent PRpositive cells was observed in Stat5a KO cells. To determine whether Stat5a is also required for progestin-induced proliferation, primary MECs in Matrigel were cultured and treated continuously with vehicle (EtOH) or R5020, and proliferation was measured by quantifying cells positive for Ki67. In both vehicle and R5020-treated cultures, Ki67 levels were decreased significantly in the Stat5a KO compared with WT ( Figure 8D ). Although R5020 gave an increased level of Ki67-positive cells in MECs from Stat5a KO mice, this was not statistically significant ( Figure 8D ). These data indicate that Sta5a is required for maximal induction of a broad group of P4 target genes, including the paracrine mediator RANKL, and for proliferation in response to P4.
Stat5a is required for P4-dependent binding of PR to selected RANKL enhancers
To explore a mechanism for why Stat5a is needed for P4 induction of RANKL, we performed ChIP assays with WT and Stat5a KO MECs to determine whether Stat5a affects PR binding to RANKL enhancers. It should be first noted that a slightly different PR binding pattern was ) were measured by gene-specific qPCR. C, Primary mouse MECs were treated with vehicle or PRL (3 g/mL) for 4.5 hours and were processed for ChIP similar to Figure 5D , but with a Stat5a antibody (sc-1081). DNA was amplified by qPCR using primers flanking each RANKL enhancer (Supplemental Figure 1) , and amplified DNA was normalized to the input. Data are presented as fold PRL-induced Stat5a recruitment (PRL/ vehicle), setting the vehicle-treated MECs to 1. Results are mean Ϯ SEM from 3 independent experiments. Student's t test was used to determine statistical significance. ns, not significant (P Ͼ .05); *, P Ͻ .05; **, P Ͻ .01; ***, P Ͻ .001. GAPDH, glyceraldehydes 3-phosphate dehydrogenase.
doi: 10.1210/me.2013-1077 mend.endojournals.orgobserved with MECs from the FVB mouse strain used here as compared with Balb/c in studies above. In addition to binding enhancers D1-D5, PR bound with enhancer D6 in a progestin-dependent manner that was not observed with Balb/c (Figure 9A) . Compared with WT KO MECs, P4 failed to stimulate binding of PR to enhancers D2, D4, D5, and D6 in the absence of Stat5a, whereas P4-induced PR recruitment was maintained at enhancers D1 and D3 ( Figure 9A ). Residual PR binding with enhancers D1 and D3 may be responsible for the weak P4 induction of RANKL observed in the absence of Stat5a ( Figure 8A ). These data suggest that Stat5a acts, at least in part, to facilitate binding of PR to specific enhancer sites. For enhancers D1 and D3 that bind PR independent of Stat5a, it is possible that Stat5a has an additional effect as a coactivator for DNA-bound PR.
Discussion
In this study a primary MEC culture system that closely resembles the morphology and functional characteristics of the intact mammary gland in vivo was used to examine the molecular mechanism by which P4 regulates expression of target gene effectors of cell proliferation including the crucial paracrine factor RANKL. Primary MECs embedded in Matrigel grow and form 3D ductal structures composed of a polarized layer of luminal epithelial and myoepthelial cells surrounding a lumen, and they maintain a heterogeneous pattern of PR-positive and -negative cells. MECs are also responsive to progestin in terms of increased proliferation and induction of a wide range of target genes identified previously to be acutely regulated by P4 in the mammary gland in vivo (13) including RANKL and Figure 7 . P4 induces recruitment of Stat5a to RANKL enhancers. A, HC-11 cells transduced to express PR-B were treated with EtOH or R5020 (100 nM) for 1 hour and were processed for ChIP with an antibody to Stat5a (sc-1081). Immunoprecipitated DNA was amplified by qPCR using primers flanking each RANKL enhancer (Supplemental Figure 1) , and amplified DNA was normalized to the input. Amount of Stat5a binding is displayed as fold R5020-induced Stat5a recruitment over EtOH, setting the value of vehicle-treated HC-11 cells to 1. B, Primary mouse MECs were treated with EtOH or P4 (100 nM) for 4.5 hours and processed for ChIP assay as in Figure 5D except DNA was immunoprecipitated with a Stat5a antibody (sc-1081). Data are presented as fold P4-induced Stat5a recruitment (P4/EtOH), setting the vehicle-treated MECs to 1. C, Immunoblot (IB) of Y694 phosphorylation of Stat5a. Primary MECs from adult virgin WT mice grown in Matrigel were analyzed by immunoblot for phosphorylated (Y694) Stat5a and total Stat5a after 1 hour treatment with vehicle, R5020 (100 nM), or PRL (3 g/mL). D, P4-induced nuclear localization of Stat5a in HC11 cells transduced with recombinant adenovirus to ectopically express mouse PR (B isoform). Cells were plated on coverslips and analyzed for intracellular localization of Stat5a and PR by IF after 2 hours of treatment with vehicle, R5020 (100 nM), or PRL (3 g/mL). Images were captured at ϫ40 magnification and are representative for each hormone treatment. Results are mean Ϯ SEM from 3 independent experiments. Student's t test was used to determine statistical significance. ns, not significant (P Ͼ .05); *, P Ͻ .05; **, P Ͻ .01; ***, P Ͻ .001.
other paracrine factors. Responses to progestin in this primary MEC culture system appear to be driven by both isoforms of PR. Although the relative amount of PR-A is higher than PR-B, both PR-A and PR-B were clearly detected by immunoblot assay ( Figure 1C ). It has been reported previously that PR-A is the predominant form of receptor expressed in the mammary gland of pubertal and mature virgin mice and that PR-B is predominantly expressed in alveoli during pregnancy (15, 45, 48, 58, 59) . Exclusive PR-A expression is based upon antibodies pur- Results are mean Ϯ SEM from 3 independent experiments. Two-way ANOVA was used to determine statistical significance. ns, not significant (P Ͼ .05); *, P Ͻ .05; **, P Ͻ .01; ***, P Ͻ .001. GAPDH, glyceraldehyde 3-phosphate dehydrogenase. Results are mean Ϯ SEM from 3 independent experiments. A two-way ANOVA was used to determine statistical significance. ns, not significant (P Ͼ .05); *, P Ͻ .05; **, P Ͻ .01; ***, P Ͻ . (60) . One possibility for the different results is that MECs in the present study were isolated from adult virgin mice at 12 weeks as opposed to 6 weeks and 18 -20 weeks in previous studies (45, 58) . PR isoform expression may differ between these stages of development. Another possibility is that previous studies simply missed expression of PR-B due to sensitivity limitations of the antibodies and conditions used. Immunoblot assays of isolated MECs from virgin mice, reported in earlier studies to confirm the exclusive expression of PR-A, gave very weak signals (58) that may be below the level of detection of PR-B given that PR-A is expressed at a higher level than PR-B ( Figure 1C ). With HC-11 cells engineered to express PR-B, P4-dependent activation of RANKL reporter genes and receptor binding by ChIP assay to RANKL enhancers was similar to that of primary MECs, indicating that PR-B alone is capable of directly regulating RANKL gene expression. Our results support the conclusion that both PR isoforms are expressed in MECs from adult virgin mice and that regulation of RANKL and other target genes is not exclusively regulated by PR-A. Using a combination of experimental approaches including RANKL reporter genes, analysis of endogenous RANKL and ChIP assays with primary MEC cultures, we demonstrated that RANKL is a direct PR target gene containing multiple distal enhancers that are functionally activated by P4 and bind PR in a progestin-dependent manner. PR bound to at least 5 enhancers located between Ϫ16 to Ϫ88 kb from the transcription start site of the gene (52, 53, 55) . A similar PR binding pattern with enhancers D1-D5 was observed in HC-11 cells and with primary MECs from Balb/c mice whereas binding to an additional sixth enhancer (D1-D6) was observed with MECs from FVB mice (Figures 5 and 9A ). This strain difference in PR binding with RANKL enhancers is perhaps not unexpected and may contribute to the previously observed mouse strain-specific differences in proliferative and morphogenic responses of mammary epithelium to P4 (48) . An unbiased ChIP-Seq analysis of genomic PR binding sites or high-density ChIP-chip tiling assays will be required to determine whether there are additional PR binding sites in RANKL that may contribute to P4-induced regulation. ChIP-Seq analysis of the PR cistrome in whole mouse uterus detected 3 PR binding sites in RANKL (61) that coincide with sites in enhancers D2 and D5 of RANKL in the present study. As evidence that PR binding to enhancers is functionally important, the loss of P4 induction of RANKL gene expression observed in MECs from Stat5a KO mice was accompanied by loss of PR binding to 4 of the 6 enhancers (Figures 8 and 9A) .
Although RANKL appears to be a direct target that binds PR, increased expression of RANKL mRNA required 48 hours of treatment with progestin, and maximal induction was observed and maintained between 72 hours out to 14 days of treatment (Figure 3 ). Progestin induction of Areg followed a similar time course, whereas Wnt4 was induced as early as 6 hours of treatment. The time course of induction of these genes in 3D MEC cultures was similar to that observed in the intact mammary gland of ovariectomized mice in vivo (11, 13) . The lag required for the maximal increase of RANKL mRNA suggests that P4 stimulation of RANKL gene expression involves both a transcriptional and posttranscriptional component. Indeed, recent studies showing the conservation of the P4-RANKL paracrine signaling axis in normal human breast epithelium observed that increased expression of RANKL was due to a combination of an increase in primary transcripts and stability of the mature RANKL mRNA (27) . Although direct binding of PR by ChIP to human RANKL promoter/enhancer regions was not performed in these studies (27) , there is substantial sequence homology (67% to 82% identity) between mouse and human in the enhancer regions that bind mouse PR in this study, suggesting that human RANKL is likely a direct transcriptional target of PR as well. An additional possible mechanism for posttranscription control of RANKL by P4 is a down-regulation of micro-RNAs that have been identified to target RANKL mRNA (62) .
Induction of RANKL by PRL was not observed with our 3D MEC cultures ( Figure 6A ). Under the same conditions PRL stimulated tyrosine phosphorylation of Stat5a ( Figure 7C ) and induction of ␤-casein ( Figure 6B ), a well-characterized target of the PRL receptor/Jak2/ Stat5a signaling pathway (63) . Thus, lack of PRL induction of RANKL was not due to a failure to activate Stat5a-mediated transcription. We also failed to observe an effect of PRL on RANKL in the presence of progestin. The induction of RANKL by P4 was unaltered by cotreatment of MECs with PRL (data not shown). Interestingly, PRL stimulated binding of Stat5a to selected RANKL enhancers by ChIP assay (Figure 6C ), but this also was not sufficient for induction of RANKL expression ( Figure 6A ). Previous reports as to whether RANKL is regulated by PRL are conflicting. With MECs isolated from ovariectomized adult virgin mice, PRL was observed to induce expression of IGF-2 but not RANKL, and it was con-cluded that RANKL was a target of P4 rather than PRL (64) . On the other hand, PRL was observed to increase RANKL mRNA expression in mammary glands of virgin PRL Ϫ/Ϫ mice in response to pituitary grafts as a method to elevate short-lived circulating PRL (37) . Induction of RANKL by direct PRL treatment of primary MECs in culture from normal virgin mice was also observed in the same study (37) . Differential gene expression analysis by microarray demonstrated a reduction of RANKL in the mammary gland of PRL receptor knockout mice further suggesting that RANKL is a target of PRL signaling (33 (Figure 7, A  and B ). It appears that Stat5a recruited by progestin in this manner is not activated as a transcription factor. The base level of tyrosine (Y694) phosphorylation of Stat5a in 3D MEC cultures was undetectable in the absence of hormone and was unaffected by treatment with progestin ( Figure 7C ). Mechanistically, how progestin stimulated binding of Stat5a to RANKL enhancers remains to be defined. This likely occurs through protein-protein interaction between Stat5a and PR. We showed by coimmunofluorescence assay of HC-11 cells transduced to express PR that acute progestin treatment stimulates translocation of both PR and Stat5a (endogenous protein) from the cytoplasm to the nucleus, and the 2 proteins colocalize in nuclei of the same cells ( Figure 7D ). These data indicate that Stat5a is carried to the nucleus by tethering with PR through protein-protein interaction. Because Stat5a translocated to nuclei in this manner is not activated by tyrosine phosphorylation (Figure 7C ), this further indicates that Stat5a in this context has a role other than that of a transcription factor, potentially as a PR coactivator. Coimmunoprecipitation of PR and Stat5a has been reported previously in breast cancer cell lines (65) , and there are other precedents as well for protein-protein and functional interactions between Stat5a and PR. For example, 11␤-hydroxysteroid dehydrogenase type 2 is a PR target gene in breast cancer cells that is induced by progestins through multiple regulatory elements including direct binding of PR to PREs at the proximal promoter and tethering of PR through Stat5a bound to distal regions of the promoter (66) . Progestin-induced expression of c-myc was recently reported to involve the assembly of a PR/Stat5/FGFR-2 complex at PRE sites in the promoter (67) . Progestin and PRL are each capable of inducing expression of Id4 (inhibitor of differentiation 4) in differentiated HC-11/PR cells whereas induction with both hormones is greater than either alone (13) . In the presence of P4 and PRL, both PR and Stat5a were recruited to the same promoter/enhancer regions of Id4 indicative of a positive cooperative interaction (13) . Progestin induction of Id4 was not detected in primary MEC 3D cultures in this study. This is likely due to the fact that Id4 induction by P4 was observed in the mammary gland primarily in early pregnancy (13) , whereas the primary MECs in the present experiments were from adult virgin mice. Id4 was induced by progestin in primary 3D cultures with MECs from pregnant mice (data not shown), and in previous studies with HC-11 cells under differentiation conditions that mimic MECs during pregnancy (13) .
This study has revealed a novel functional role for Stat5a in PR-mediated activation of RANKL gene expression. This was demonstrated by cobinding of Stat5a and PR to RANKL enhancers in response to progestin and by the observation that progestin induction of RANKL expression was abrogated in the absence of Stat5a ( Figures  5 and 8) . As a mechanism for Stat5a dependency, the loss of progestin-dependent binding of PR with multiple RANKL enhancers (D2 and D4-D6) in the absence of Stat5a indicates that Stat5a acts, in part, by facilitating PR DNA binding ( Figure 9A ). Other Stat5a interactions may be involved at RANKL enhancers (D1 and D3) in which PR DNA binding is not dependent on Stat5a ( Figure 9A ). As modeled in Figure 9B , the results of this study support the conclusion that PR and Stat5a cobind with multiple RANKL enhancers and that cooperative interactions between the 2 proteins are required for maximal induction by P4. Enhancers D4, D5, and D6 are proposed to be composite response elements composed of weak PRE half-sites neighboring Stat5 GAS elements such that PR and Stat5a together form a stable interaction with DNA, whereas either protein alone does not ( Figure 9B ). Enhancer D2 is interesting because this is the only site at which Stat5a was not recruited by P4, yet PR binding was dependent on Stat5a. This suggests the possibility of longrange DNA looping between enhancers in the context of chromatin, whereby Stat5a recruited to other enhancers has the opportunity to interact with PR at enhancer D2. Previous studies have shown an interaction by DNA looping between glucocorticoid receptors and Stat5 bound to distal enhancers and the promoter of ␤-casein in mouse MECs, and that this can be disrupted by PR (68 Figure 9B ). Stat5a has 2 serine phosphorylation sites in the C-terminal transcriptional activation domain that are important for its transcriptional activity (69) . The serine phosphorylation state of Stat5a recruited to the RANKL enhancers by P4 is not known. It is possible that Stat5a is tethered via protein-protein interaction to DNA-bound PR at enhancers D1 and D3 to provide additional transcriptional activation domains or protein interaction surfaces for assembly of a coactivator complex. Further molecular studies are required to define the mechanisms of Stat5a and PR interactions at each individual RANKL enhancer.
In vivo studies of the mammary gland of Stat5a-null mice have reported a decrease of both cell proliferation and stimulation of RANKL expression in response to treatment with estrogen and P4 (6, 31, 34, 48) . Similar findings in the present study provide additional validation of our in vitro experimental system; in addition it provides further mechanistic data on the role of Stat5a specifically for P4-mediated signaling in the absence of estrogen. Another member of the Stat family, Stat3, was recently reported to have a novel role as a PR coactivator in breast cancer cells. By ChIP assay Stat3 and PR were observed to be recruited together as a complex in response to progestin on promoters of selected PR target genes. The presence of Stat3 in the complex was further shown to be required for PR-mediated transcriptional activation of these genes (70) . In summary, our studies define a role for Stat5a, independent of its function as a transcriptional activator, as a PR cofactor required for P4 induction of RANKL expression in mouse MECs. Stat5a was also required for progestin regulation of a broad range of PR target genes including other key paracrine factor mediators of proliferation such as Areg and Wnt4. ChIP-Seq experiments to identify genomic patterns of PR and Stat5a binding sites in MECs will be needed to determine the extent of Stat5a -PR interactions with other target genes.
